Skip to main content
Top
Published in: Endocrine 1/2014

Open Access 01-09-2014 | Original Article

Hypothalamic–pituitary–adrenal axis activity, personality traits, and BCL1 and N363S polymorphisms of the glucocorticoid receptor gene in metabolically obese normal-weight women

Authors: Joanna Porzezińska-Furtak, Barbara Krzyżanowska-Świniarska, Tomasz Miazgowski, Krzysztof Safranow, Ryszard Kamiński

Published in: Endocrine | Issue 1/2014

Login to get access

Abstract

We sought associations among metabolic profiles, copeptin levels, emotional control, personality traits, and hypothalamic–pituitary–adrenal axis activity in metabolically obese normal-weight young women (MONW). We assessed body composition, including fat-free mass; body fat (BF) and android and gynoid fat depots; fasting blood glucose, insulin, copeptin, cortisol (baseline and after dexamethasone), adrenocorticotropin (ACTH), triglycerides, total cholesterol, low- (LDL) and high-density (HDL) lipoproteins; and the BCL1 and N363S polymorphisms of the glucocorticoid receptor gene in 59 MONW and 71 healthy women aged 20–40 years. We also evaluated personality traits using the NEO-Five Factor Inventory and the subjective extent of emotional suppression by the Courtauld Emotional Control Scale. Compared to the controls, MONW had significantly higher insulin, cholesterol, LDL, triglycerides, and waist circumference, but lower HDL. MONW also had increased BF (>30 % of weight) and unfavorable regional fat distribution with excess android fat. The android/BF ratio was 8.29 % (MONW) versus 7.89 % (controls) (p = 0.005), while the gynoid/BF ratio was 31.99 versus 34.1 %, respectively (p = 0.008). Despite similar ACTH levels in both groups, MONW had higher cortisol levels both at the baseline (p < 0.001) and in the dexamethasone suppression test (p = 0.003). Copeptin levels and the distribution of glucocorticoid receptor polymorphisms were similar in both groups. There were also no significant differences in psychological features between MONW and controls. In conclusion, the MONW phenotype was associated with hypothalamic–pituitary–adrenal axis dysregulation, unfavorable metabolic profiles, and fat accumulation, but normal distribution of glucocorticoid receptor gene polymorphisms and copeptin levels, and no significant differences in psychological features between MONW and controls.
Literature
1.
go back to reference N.B. Ruderman, P. Brechtold, S.H. Schneider, Obesity associated disorders in normal weight individuals: some speculations. Int. J. Obes. 6, 151–157 (1982)PubMed N.B. Ruderman, P. Brechtold, S.H. Schneider, Obesity associated disorders in normal weight individuals: some speculations. Int. J. Obes. 6, 151–157 (1982)PubMed
2.
go back to reference A. Katsuki, Y. Sumida, H. Urakawa, Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 26, 2341–2344 (2003)PubMedCrossRef A. Katsuki, Y. Sumida, H. Urakawa, Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 26, 2341–2344 (2003)PubMedCrossRef
3.
go back to reference F. Conus, D.B. Allison, R. Rabasa-Lhoret, M. St-Onge, D.H. St-Pierre, A. Tremblay-Lebeau, E.T. Poehlman, Metabolic and behavioral characteristic of metabolically obese but normal-weight women. J. Clin. Endocrinol. Metab. 89, 5013–5020 (2004)PubMedCrossRef F. Conus, D.B. Allison, R. Rabasa-Lhoret, M. St-Onge, D.H. St-Pierre, A. Tremblay-Lebeau, E.T. Poehlman, Metabolic and behavioral characteristic of metabolically obese but normal-weight women. J. Clin. Endocrinol. Metab. 89, 5013–5020 (2004)PubMedCrossRef
4.
go back to reference R.V. Dvorak, W.F. DeNino, P.A. Ades, Phenotypic characteristics associated with insulin resistance in metabolically obese but normal weight young women. Diabetes 48, 2210–2214 (1998)CrossRef R.V. Dvorak, W.F. DeNino, P.A. Ades, Phenotypic characteristics associated with insulin resistance in metabolically obese but normal weight young women. Diabetes 48, 2210–2214 (1998)CrossRef
5.
go back to reference J.B. Meigs, P.W. Wilson, C.S. Fox, R.S. Vasan, D.M. Nathan, L.M. Sullivan, R.B. D’Agostino, Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 91, 2906–2912 (2006)PubMedCrossRef J.B. Meigs, P.W. Wilson, C.S. Fox, R.S. Vasan, D.M. Nathan, L.M. Sullivan, R.B. D’Agostino, Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 91, 2906–2912 (2006)PubMedCrossRef
6.
go back to reference M.P. St-Onge, I. Janssen, S.B. Heymsfield, Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care 27, 2222–2228 (2004)PubMedCrossRef M.P. St-Onge, I. Janssen, S.B. Heymsfield, Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care 27, 2222–2228 (2004)PubMedCrossRef
7.
go back to reference N.B. Ruderman, D. Chisholm, X. Pi-Sunyer, S. Schneider, The metabolically obese, normal-weight individual revisited. Diabetes 47, 699–713 (1998)PubMedCrossRef N.B. Ruderman, D. Chisholm, X. Pi-Sunyer, S. Schneider, The metabolically obese, normal-weight individual revisited. Diabetes 47, 699–713 (1998)PubMedCrossRef
8.
go back to reference E. Succurro, M.A. Marini, S. Frontoni, M.L. Hribal, F. Andreozzi, R. Lauro, F. Perticone, G. Sesti, Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity 16, 1881–1886 (2008)PubMedCrossRef E. Succurro, M.A. Marini, S. Frontoni, M.L. Hribal, F. Andreozzi, R. Lauro, F. Perticone, G. Sesti, Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity 16, 1881–1886 (2008)PubMedCrossRef
9.
go back to reference E. Molero-Conejo, L.M. Morales, V. Fernández, X. Raleigh, M.E. Gómez, M. Semprún-Fereira, G. Campos, E. Ryder, Lean adolescents with increased risk for metabolic syndrome. Arch. Latinoam. Nutr. 53, 39–46 (2003)PubMed E. Molero-Conejo, L.M. Morales, V. Fernández, X. Raleigh, M.E. Gómez, M. Semprún-Fereira, G. Campos, E. Ryder, Lean adolescents with increased risk for metabolic syndrome. Arch. Latinoam. Nutr. 53, 39–46 (2003)PubMed
10.
go back to reference B.H. Goodpaster, S. Krishnaswami, H. Resnick, D.E. Kelley, C. Haggerty, T.B. Harris, A.V. Schwartz, S. Kritchevsky, A.B. Newman, Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26, 372–379 (2003)PubMedCrossRef B.H. Goodpaster, S. Krishnaswami, H. Resnick, D.E. Kelley, C. Haggerty, T.B. Harris, A.V. Schwartz, S. Kritchevsky, A.B. Newman, Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26, 372–379 (2003)PubMedCrossRef
11.
go back to reference K.M. Choi, H.J. Cho, H.Y. Choi, S.J. Yang, H.J. Yoo, J.A. Seo, S.G. Kim, S.H. Baik, D.S. Choi, N.H. Kim, Higher mortality in metabolically obese normal weight people than in metabolically healthy obese subjects in elderly Koreans. Clin. Endocrinol. (Oxf) 79, 364–370 (2013)CrossRef K.M. Choi, H.J. Cho, H.Y. Choi, S.J. Yang, H.J. Yoo, J.A. Seo, S.G. Kim, S.H. Baik, D.S. Choi, N.H. Kim, Higher mortality in metabolically obese normal weight people than in metabolically healthy obese subjects in elderly Koreans. Clin. Endocrinol. (Oxf) 79, 364–370 (2013)CrossRef
12.
go back to reference J.L. Shea, M.T. King, Y. Yi, W. Gulliver, G. Sun, Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects. Nutr. Metab. Cardiovasc. Dis. 22, 741–747 (2012)PubMedCrossRef J.L. Shea, M.T. King, Y. Yi, W. Gulliver, G. Sun, Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects. Nutr. Metab. Cardiovasc. Dis. 22, 741–747 (2012)PubMedCrossRef
13.
go back to reference R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, J. Wylie-Rosett, M.R. Sowers, The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch. Intern. Med. 168, 1617–1624 (2008)PubMedCrossRef R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, J. Wylie-Rosett, M.R. Sowers, The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch. Intern. Med. 168, 1617–1624 (2008)PubMedCrossRef
14.
go back to reference S. Wallerius, R. Rosmond, T. Ljung, G. Holm, P. Björntorp, Rise in morning saliva cortisol is associated with abdominal obesity in men: a preliminary report. J. Endocrinol. Invest. 26, 616–619 (2003)PubMedCrossRef S. Wallerius, R. Rosmond, T. Ljung, G. Holm, P. Björntorp, Rise in morning saliva cortisol is associated with abdominal obesity in men: a preliminary report. J. Endocrinol. Invest. 26, 616–619 (2003)PubMedCrossRef
15.
go back to reference D.I. Phillips, D.J. Barker, C.H. Fall, J.R. Seckl, C.B. Whorwood, P.J. Wood, B.R. Walker, Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J. Clin. Endocrinol. Metab. 83, 757–760 (1998)PubMed D.I. Phillips, D.J. Barker, C.H. Fall, J.R. Seckl, C.B. Whorwood, P.J. Wood, B.R. Walker, Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J. Clin. Endocrinol. Metab. 83, 757–760 (1998)PubMed
16.
go back to reference S.M. Smith, W.W. Vale, The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci. 8, 383–395 (2006)PubMedCentralPubMed S.M. Smith, W.W. Vale, The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci. 8, 383–395 (2006)PubMedCentralPubMed
17.
go back to reference D. Savic, G. Knezevic, S. Damjanovic, Z. Spiric, G. Matic, The role of personality and traumatic events in cortisol levels-where does PTSD fit in? Psychoneuroendocrinology 37, 937–947 (2012)PubMedCrossRef D. Savic, G. Knezevic, S. Damjanovic, Z. Spiric, G. Matic, The role of personality and traumatic events in cortisol levels-where does PTSD fit in? Psychoneuroendocrinology 37, 937–947 (2012)PubMedCrossRef
18.
go back to reference M. Katan, M. Christ-Crain, The stress hormone copeptin: a new prognostic biomarker in acute illness. Swiss Med Wkly 24(140), w13101 (2010) M. Katan, M. Christ-Crain, The stress hormone copeptin: a new prognostic biomarker in acute illness. Swiss Med Wkly 24(140), w13101 (2010)
19.
go back to reference U. Saleem, M. Khaleghi, N.G. Morgenthaler, A. Bergmann, J. Struck, T.H. Mosley Jr, Kullo IJ: plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J. Clin. Endocrinol. Metab. 94, 2558–2564 (2009)PubMedCentralPubMedCrossRef U. Saleem, M. Khaleghi, N.G. Morgenthaler, A. Bergmann, J. Struck, T.H. Mosley Jr, Kullo IJ: plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J. Clin. Endocrinol. Metab. 94, 2558–2564 (2009)PubMedCentralPubMedCrossRef
20.
go back to reference S. Enhörning, L. Bankir, N. Bouby, J. Struck, B. Hedblad, M. Persson, N.G. Morgenthaler, P.M. Nilsson, O. Melander, Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort. Int. J. Obes. (Lond) 37, 598–603 (2013)CrossRef S. Enhörning, L. Bankir, N. Bouby, J. Struck, B. Hedblad, M. Persson, N.G. Morgenthaler, P.M. Nilsson, O. Melander, Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort. Int. J. Obes. (Lond) 37, 598–603 (2013)CrossRef
21.
go back to reference S. Wüst, E.F. Van Rossum, I.S. Federenko, J.W. Koper, R. Kumsta, D.H. Hellhammer, Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J. Clin. Endocrinol. Metab. 89, 565–573 (2004)PubMedCrossRef S. Wüst, E.F. Van Rossum, I.S. Federenko, J.W. Koper, R. Kumsta, D.H. Hellhammer, Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J. Clin. Endocrinol. Metab. 89, 565–573 (2004)PubMedCrossRef
22.
go back to reference P. Barat, M. Duclos, B. Gatta, P. Roger, P. Mormede, M.P. Moisan, Corticosteroid binding globulin gene polymorphism influences cortisol driven fat distribution in obese women. Obes. Res. 13, 1485–1490 (2005)PubMedCrossRef P. Barat, M. Duclos, B. Gatta, P. Roger, P. Mormede, M.P. Moisan, Corticosteroid binding globulin gene polymorphism influences cortisol driven fat distribution in obese women. Obes. Res. 13, 1485–1490 (2005)PubMedCrossRef
23.
go back to reference M.G. Dobson, C.P. Redfern, N. Unwin, J.U. Weaver, The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J. Clin. Endocrinol. Metab. 86, 2270–2274 (2001)PubMed M.G. Dobson, C.P. Redfern, N. Unwin, J.U. Weaver, The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J. Clin. Endocrinol. Metab. 86, 2270–2274 (2001)PubMed
24.
go back to reference A.M. Ward, C.H. Fall, C.E. Stein, K. Kumaran, S.R. Veena, P.J. Wood, H.E. Syddall, D.I. Phillips, Cortisol and the metabolic syndrome in South Asians. Clin. Endocrinol. (Oxf) 58, 500–505 (2003)CrossRef A.M. Ward, C.H. Fall, C.E. Stein, K. Kumaran, S.R. Veena, P.J. Wood, H.E. Syddall, D.I. Phillips, Cortisol and the metabolic syndrome in South Asians. Clin. Endocrinol. (Oxf) 58, 500–505 (2003)CrossRef
25.
go back to reference P. Marin, N. Darin, T. Amemiya, B. Andersson, S. Jern, P. Bjorntorp, Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 41, 882–886 (1992)PubMedCrossRef P. Marin, N. Darin, T. Amemiya, B. Andersson, S. Jern, P. Bjorntorp, Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 41, 882–886 (1992)PubMedCrossRef
26.
go back to reference R. Pasquali, B. Anconetani, R. Chattat, M. Biscotti, G. Spinucci, F. Casimirri, V. Vicennati, Carcello Carcello A, Labate AM: hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Metabolism 45, 351–356 (1996)PubMedCrossRef R. Pasquali, B. Anconetani, R. Chattat, M. Biscotti, G. Spinucci, F. Casimirri, V. Vicennati, Carcello Carcello A, Labate AM: hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Metabolism 45, 351–356 (1996)PubMedCrossRef
27.
go back to reference S.B. Abraham, D. Rubino, N. Sinaii, S. Ramsey, L.K. Nieman, Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature. Obesity (Silver Spring) 21, E105–E117 (2013)CrossRef S.B. Abraham, D. Rubino, N. Sinaii, S. Ramsey, L.K. Nieman, Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature. Obesity (Silver Spring) 21, E105–E117 (2013)CrossRef
28.
go back to reference E.F. van Rossum, J.W. Koper, A.W. van den Beld, A.G. Uitterlinden, P. Arp, W. Ester, J.A. Janssen, A.O. Brinkmann, F.H. de Jong, D.E. Grobbee, H.A. Pols, S.W. Lamberts, Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin. Endocrinol. (Oxf) 59, 585–592 (2003)CrossRef E.F. van Rossum, J.W. Koper, A.W. van den Beld, A.G. Uitterlinden, P. Arp, W. Ester, J.A. Janssen, A.O. Brinkmann, F.H. de Jong, D.E. Grobbee, H.A. Pols, S.W. Lamberts, Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin. Endocrinol. (Oxf) 59, 585–592 (2003)CrossRef
29.
go back to reference A. Stevens, D.W. Ray, E. Zeggini, S. John, H.L. Richards, C.E. Griffiths, R. Donn, Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J. Clin. Endocrinol. Metab. 89, 892–897 (2004)PubMedCrossRef A. Stevens, D.W. Ray, E. Zeggini, S. John, H.L. Richards, C.E. Griffiths, R. Donn, Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J. Clin. Endocrinol. Metab. 89, 892–897 (2004)PubMedCrossRef
30.
go back to reference R.C. Lin, X.L. Wang, B.J. Morris, Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension 2003(41), 404–407 (2003)CrossRef R.C. Lin, X.L. Wang, B.J. Morris, Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension 2003(41), 404–407 (2003)CrossRef
31.
go back to reference A.M. Di Blasio, E.F. van Rossum, S. Maestrini, M.E. Berselli, M. Tagliaferri, F. Podestà, J.W. Koper, A. Liuzzi, S.W. Lamberts, The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin. Endocrinol. (Oxf) 59, 68–74 (2003)CrossRef A.M. Di Blasio, E.F. van Rossum, S. Maestrini, M.E. Berselli, M. Tagliaferri, F. Podestà, J.W. Koper, A. Liuzzi, S.W. Lamberts, The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin. Endocrinol. (Oxf) 59, 68–74 (2003)CrossRef
32.
go back to reference K. Ahola, L. Pulkki-Råback, A. Kouvonen, H. Rossi, A. Aromaa, J. Lönnqvist, Burnout and behavior-related health risk factors: results from the population-based Finnish Health 2000 Study. J. Occup. Environ. Med. 54, 17–22 (2012)PubMedCrossRef K. Ahola, L. Pulkki-Råback, A. Kouvonen, H. Rossi, A. Aromaa, J. Lönnqvist, Burnout and behavior-related health risk factors: results from the population-based Finnish Health 2000 Study. J. Occup. Environ. Med. 54, 17–22 (2012)PubMedCrossRef
33.
go back to reference E. Melcescu, M. Griswold, L. Xiang, S. Belk, D. Montgomery, M. Bray, K.S. Del Ben, G.I. Uwaifo, G.D. Marshall, C.A. Koch, Prevalence and cardiometabolic associations of the glucocorticoid receptor gene polymorphisms N363S and Bcl1 in obese and non-obese black and white Mississippians. Hormones (Athens) 11, 166–177 (2012)CrossRef E. Melcescu, M. Griswold, L. Xiang, S. Belk, D. Montgomery, M. Bray, K.S. Del Ben, G.I. Uwaifo, G.D. Marshall, C.A. Koch, Prevalence and cardiometabolic associations of the glucocorticoid receptor gene polymorphisms N363S and Bcl1 in obese and non-obese black and white Mississippians. Hormones (Athens) 11, 166–177 (2012)CrossRef
34.
go back to reference S. Branth, G. Ronquist, M. Stridsberg, L. Hambraeus, E. Kindgren, R. Olsson, D. Carlander, B. Arnetz, Development of abdominal fat and incipient metabolic syndrome in young healthy men exposed to long-term stress. Nutr. Metab. Cardiovasc. Dis. 17, 427–435 (2007)PubMedCrossRef S. Branth, G. Ronquist, M. Stridsberg, L. Hambraeus, E. Kindgren, R. Olsson, D. Carlander, B. Arnetz, Development of abdominal fat and incipient metabolic syndrome in young healthy men exposed to long-term stress. Nutr. Metab. Cardiovasc. Dis. 17, 427–435 (2007)PubMedCrossRef
35.
go back to reference G. Bednarek Tupikowska, B. Stachowska, T. Miazgowski, B. Krzyżanowska-Świniarska, B. Katra, Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population. Endokrynol. Pol. 63, 447–455 (2012)PubMed G. Bednarek Tupikowska, B. Stachowska, T. Miazgowski, B. Krzyżanowska-Świniarska, B. Katra, Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population. Endokrynol. Pol. 63, 447–455 (2012)PubMed
Metadata
Title
Hypothalamic–pituitary–adrenal axis activity, personality traits, and BCL1 and N363S polymorphisms of the glucocorticoid receptor gene in metabolically obese normal-weight women
Authors
Joanna Porzezińska-Furtak
Barbara Krzyżanowska-Świniarska
Tomasz Miazgowski
Krzysztof Safranow
Ryszard Kamiński
Publication date
01-09-2014
Publisher
Springer US
Published in
Endocrine / Issue 1/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0187-0

Other articles of this Issue 1/2014

Endocrine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.